BGLC - BioNexus Gene Lab Corp
2.5
-0.080 -3.200%
Share volume: 5,706
Last Updated: 03-06-2026
Healthcare/Services – Health:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.58
-0.08
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-15-2024 | 05-15-2025 | 11-14-2025 | |
| Total revenue | 2.382 M | 1.975 M | 2.630 M | 2.137 M | 2.544 M | |
| Cost of revenue | 2.017 M | 1.686 M | 2.304 M | 1.768 M | 2.166 M | |
| Gross profit | 365.031 K | 288.720 K | 326.536 K | 343.493 K | 377.685 K | |
| -20.91% | 13.10% | 5.19% | 9.95% | |||
| Operating expenses | 645.906 K | 759.657 K | 2.130 M | 404.015 K | 460.567 K | |
| Selling general and admin | 645.906 K | 759.657 K | 2.130 M | 391.876 K | 445.691 K | |
| Research and development | 0.000 | 0.000 | 0.000 | 12.139 K | 14.876 K | |
| Total expenses | 645.906 K | 29.552 K | 2.130 M | 973.083 K | 1.148 M | |
| -95.42% | 7,106.57% | -54.31% | 17.93% | |||
| Operating income | -79.028 K | 259.168 K | -1.338 M | -618.418 K | -702.509 K | |
| Ebit | 98.090 K | 254.688 K | -872.095 K | -589.167 K | -660.133 K | |
| Pretax income | -83.689 K | 254.688 K | -1.344 M | -623.327 K | -708.991 K | |
| -404.33% | -627.63% | -53.62% | 13.74% | |||
| Income tax | 0.000 | -55.584 K | 1.555 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -103.757 K | 199.104 K | -1.345 M | -543.079 K | -708.991 K | |
| 291.89% | -775.71% | 59.63% | -30.55% |